Article: CIBA VISION AND QLT TO EXPAND STRATEGIC ALLIANCE.

:: Companies to Seek Out and Co-Develop New Treatments for Eye Diseases

:: PR Newswire, London, April 17. This press release is transmitted on behalf of CIBA Vision

Atlanta and Vancouver, British Columbia - CIBA Vision, the eye care unit of Novartis, and QLT PhotoTherapeutics Inc. (Nasdaq: QLTI; Toronto) have agreed to broaden their partnership to actively develop other compounds used either alone or in combination with photodynamic therapy agents to treat diseases characterised by neovascularisation, a growth of abnormal blood vessels in the eye. Age-related macular degeneration (AMD) is one of a number of ocular diseases caused by this condition; ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!